Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer
Zangardi, Mark L., Spring, Laura M., Blouin, Gayle C., Bardia, AdityaLanguage:
english
Journal:
Expert Review of Clinical Pharmacology
DOI:
10.1080/17512433.2017.1376653
Date:
September, 2017
File:
PDF, 978 KB
english, 2017